ProQR Therapeutics

-$0.04 (-0.59%) Today
$0.00 (0.00%) As of 12:00 AM UTC after-hours

Why Robinhood?

You can buy or sell PRQR and other stocks, options, and ETFs commission-free!

About PRQR

ProQR Therapeutics N.V. Ordinary Shares, also called ProQR Therapeutics, is a biopharmaceutical company, which engages in the discovery and development of RNA therapies for the treatment of severe genetic rare diseases such as Leber congenital amaurosis 10, Usher syndrome and retinitis pigmentosa.

CEO
Daniel Anton de Boer
Employees
150
Headquarters
Leiden, Zuid-Holland
Founded
2012

PRQR Key Statistics

Market Cap
432.98M
Price-Earnings Ratio
—
Dividend Yield
0.00
Average Volume
484.20K
High Today
$6.85
Low Today
$6.58
Open Price
$6.69
Volume
397.61K
52 Week High
$9.46
52 Week Low
$3.40

PRQR Earnings

-$0.43
-$0.29
-$0.14
$0.00
Q3 FY19
Q4 FY19
Q1 FY20
Q2 FY20
Q3 FY20
Q4 FY20
Q1 FY21
Q2 FY21
Estimated
— per share
Actual
Expected Aug 5, Pre-Market
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, a registered broker-dealer and Member SIPC. Full disclosure